Harmony Biosciences Holdings (HRMY) Treasury Shares (2020 - 2026)

Harmony Biosciences Holdings has disclosed Treasury Shares across 7 years of filings, most recently posting $1.0 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $1.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (changed N/A YoY), and the FY2025 annual result was $796498.0, up 24.67% from the prior year.
• Treasury Shares came in at $1.0 million for Q1 2026 at Harmony Biosciences Holdings, up from $796498.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.0 million in Q1 2026 to a low of $30000.0 in Q1 2023.
• The 5-year median for Treasury Shares is $330000.0 (2023), against an average of $406836.4.
• Across the five-year window, Treasury Shares plunged 30.57% in 2023 and soared 2240.5% in 2024, its largest moves.
• Harmony Biosciences Holdings' Treasury Shares stood at $60000.0 in 2022, then jumped by 450.0% to $330000.0 in 2023, then soared by 93.61% to $638900.0 in 2024, then climbed by 24.67% to $796498.0 in 2025, then surged by 31.69% to $1.0 million in 2026.
• The last three Treasury Shares figures came in at $1.0 million (Q1 2026), $796498.0 (Q4 2025), and $799587.0 (Q3 2025), per Business Quant data.